VECTUS BIOSYSTEMS LIMITED — Director's Dealing 2023

Jan 19, 2023

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Vectus Biosystems Limited (ASX:VBS) ABN 54 117 526 137

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Maurie Stang
Date of last notice	30 December 2022

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

be disclosed in this part.
Direct or indirect interest	Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Energy Trading Systems Pty Ltd Maurie Stang is the sole shareholder of the trustee, Energy Trading Systems Pty Ltd, and he is a beneficiary of The MPF Trust. Meditsuper Pty Ltd Maurie Stang is a 50% holder in the trust. Maurie Stang is a 50% shareholder of each of the following companies: Stangcorp Pty Ltd Epitek Corporation Pty Ltd 247 Church Street Pty Ltd Ramlist Pty Ltd Regional Health Care Group Pty Ltd Teknik Pty Ltd
Date of change	14 December 2022

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change	2,562,500 fully paid ordinary shares in the name of Energy Trading Systems Pty Ltd 2,285,952 fully paid ordinary shares in the name of Maurie Stang 1,500 fully paid ordinary shares in the name of Meditsuper Pty Ltd 1,500 fully paid ordinary shares in the name of Stangcorp Pty Ltd 1,500 fully paid ordinary shares in the name of Epitek Corporation Pty Ltd 1,500 fully paid ordinary shares in the name of 247 Church Street Pty Ltd 1,500 fully paid ordinary shares in the name of Ramlist Pty Ltd 1,500 fully paid ordinary shares in the name of Regional Health Care Group Pty Ltd 1,500 fully paid ordinary shares in the name of Teknik Pty Ltd
Class	Options
Number acquired	316,000
Number disposed	Nil
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	Not issued for cash consideration, but as total amount of Mr Stang’s remuneration by Vectus for 6.33 years ended on 31 December 2021; remuneration for services as a Non-Executive Director and Deputy Chairman (refer 2022 Notice of Annual General Meeting (AGM) for further details).

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change

2,562,500 fully paid ordinary shares in the name of Energy Trading Systems Pty Ltd 2,285,952 fully paid ordinary shares in the name of Maurie Stang 1,500 fully paid ordinary shares in the name of Meditsuper Pty Ltd 1,500 fully paid ordinary shares in the name of Stangcorp Pty Ltd 1,500 fully paid ordinary shares in the name of Epitek Corporation Pty Ltd 1,500 fully paid ordinary shares in the name of 247 Church Street Pty Ltd 1,500 fully paid ordinary shares in the name of Ramlist Pty Ltd 1,500 fully paid ordinary shares in the name of Regional Health Care Group Pty Ltd 1,500 fully paid ordinary shares in the name of Teknik Pty Ltd 316,000 options (nil exercise price, expiring on 23 November 2026) in the name of Maurie Stang

Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

Issued under Employee Incentive Plan, following shareholder approval at 23 November 2022 AGM, as detailed in Appendix 3G lodged with ASX on 15 December 2022.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

be disclosed in this part.
Detail of contract	None
Nature of interest
Name of registered holder(if issued securities)
**Date of change **
No. and class of securities to which interest related prior to change Note: Details are onlyrequired for a contract in relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation
Interest after change
Part 3 – +Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?		No
If so, wasprior written clearanceprovided to allow the trade toproceed during thisperiod?
If prior written clearance was provided, on what date was this provided?

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3